Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Czechia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20061
20072
20103
20112
20121
20163
20172
20201
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated3
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ACADIA Pharmaceuticals Inc.3
H. Lundbeck A/S3
Boehringer Ingelheim2
Hoffmann-La Roche2
Janssen Research & Development, LLC2
Janssen-Cilag International NV2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Solvay Pharmaceuticals2
Eli Lilly and Company1
European Group for Research In Schizophrenia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia23
Psychotic Disorders4
Bipolar Disorder1
Body Weight Changes1
Cognitive Dysfunction1
Recurrence1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.